You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PK comparability between two different dose concentrations

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial in Hialeah (Amlitelimab DP1, Amlitelimab DP2)

Active, not recruiting
  • Healthy Volunteers
  • Amlitelimab DP1
  • Amlitelimab DP2
  • Hialeah, Florida
    Clinical Pharmacology of Miami-Site Number: 8400001
Mar 29, 2023

Healthy Volunteers Trial in Austin (CC-93538)

Completed
  • Healthy Volunteers
  • Austin, Texas
    PPD Phase 1 Clinic
Sep 24, 2021

Diabetes, Type 2, Healthy Participants Trial in Cypress (Semaglutide B, 1.34 mg/mL, Semaglutide B, 0.68 mg/mL)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Healthy Participants
  • Semaglutide B, 1.34 mg/mL
  • Semaglutide B, 0.68 mg/mL
  • Cypress, California
    Novo Nordisk Investigational Site
Jan 9, 2023

Wheat Hypersensitivity, Immunotherapy Trial in Bangkoknoi (Wheat (Four times per week))

Recruiting
  • Wheat Hypersensitivity
  • Immunotherapy
  • Wheat (Four times per week)
  • Bangkoknoi, Bangkok, Thailand
    Siriraj Hospital
Sep 12, 2023

Healthy Volunteers, Type 2 Diabetes Trial in Overland Park (Semaglutide D Dose 1, Semaglutide D Dose 2, Semaglutide D Dose 3)

Active, not recruiting
  • Healthy Volunteers
  • Type 2 Diabetes
  • Semaglutide D Dose 1
  • +5 more
  • Cypress, California
  • +2 more
Dec 27, 2022

Healthy Volunteers, Overweight, Obesity Trial in Neuss (Semaglutide)

Completed
  • Healthy Volunteers
  • +2 more
  • Neuss, Germany
    Novo Nordisk Investigational Site
Jan 6, 2022

Corona Virus Disease Trial in United States (AZD7442, AZD8895 (clonal cell line material), AZD1061 (clonal cell line material))

Active, not recruiting
  • Corona Virus Disease
  • AZD7442
  • +4 more
  • Anniston, Alabama
  • +12 more
Aug 12, 2022

Covid19 Trial in United States (sotrovimab)

Recruiting
  • Covid19
  • sotrovimab
  • Riverside, California
  • +9 more
Nov 2, 2022

Overweight, Obesity Trial in Neuss (Semaglutide)

Completed
  • Overweight
  • Obesity
  • Neuss, Germany
    Novo Nordisk Investigational Site
Nov 10, 2021

Fabry Disease Trial in Canada (agalsidase alfa)

Completed
Has Results
  • Fabry Disease
  • agalsidase alfa
  • Edmonton, Alberta, Canada
  • +4 more
Jul 15, 2021

Edematous Fibrosclerotic Panniculopathy, Cellulite, Laxity; Skin Trial in Coral Gables, Metairie, New York (EN3835)

Completed
  • Edematous Fibrosclerotic Panniculopathy
  • +2 more
  • Coral Gables, Florida
  • +2 more
Nov 12, 2021

Rheumatoid Arthritis Trial in Berlin, Amman (ianalumab)

Active, not recruiting
  • Rheumatoid Arthritis
  • ianalumab
  • Berlin, Germany
  • +1 more
Oct 14, 2022

Cachexia Trial in Ruddington (Part 1 Group 1 (ACM-001.1and Pindolol and Placebo), Part 1 Group 2 (Pindolol), Part 2 Group D

Completed
  • Cachexia
  • Part 1 Group 1 (ACM-001.1and Pindolol and Placebo)
  • +5 more
  • Ruddington, United Kingdom
    Quotient Sciences Ltd
Aug 31, 2023

Malaria Trial (Piperaquine Phosphate)

Not yet recruiting
  • Malaria
  • Piperaquine Phosphate
  • (no location specified)
Jun 26, 2023

Medical Device Derived Pharmacokinetic Parameters for Vancomycin

Not yet recruiting
  • Infection, Bacterial
  • +7 more
  • Drug Infusion Pump Monitoring
  • London, United Kingdom
    St Georges University Hospitals NHS Foundation Trust
Jul 10, 2023

Hiv Trial in Cape Town (Tenofovir alafenamide, Tenofovir Disoproxil Fumarate)

Recruiting
  • Hiv
  • Tenofovir alafenamide
  • Tenofovir Disoproxil Fumarate
  • Cape Town, South Africa
    Gugulethu Midwife Obstetric Unit
Nov 1, 2022

Healthy Volunteers (Diabetes, Type 2) Trial in Harrow (Semaglutide B, 1.34 mg/mL, Semaglutide D, 1.0 mg/mL)

Completed
  • Healthy Volunteers (Diabetes Mellitus, Type 2)
  • Semaglutide B, 1.34 mg/mL
  • Semaglutide D, 1.0 mg/mL
  • Harrow, Middlesex, United Kingdom
    Novo Nordisk Investigational Site
Jan 29, 2023

Healthy Volunteers Trial in Saint Paul (Dupilumab (SAR231893))

Completed
  • Healthy Volunteers
  • Dupilumab (SAR231893)
  • Saint Paul, Minnesota
    Prism Research-Site Number:840001
Jul 28, 2023

Natural Blood and Blood Product Toxicity Trial in Dhaka (Erythropoietin alpha)

Completed
  • Natural Blood and Blood Product Toxicity
  • Erythropoietin alpha
  • Dhaka, Bangladesh
  • +1 more
Oct 18, 2022

Type 1 Diabetes, Hypoglycemia, Type1diabetes Trial in Hellerup (Infusion of either NST or at different blood glucose levels)

Recruiting
  • Type 1 Diabetes
  • +2 more
  • Infusion of either NST or placebo at different blood glucose levels
  • Hellerup, Denmark
    Center for Clinical Metabolic Research, Gentofte Hospital
Nov 15, 2023

Adalimumab Trial in Cypress, South Miami, Salt Lake City (ABP 501-HCF, ABP 501-LCF)

Completed
  • Adalimumab
  • ABP 501-HCF
  • ABP 501-LCF
  • Cypress, California
  • +2 more
Jun 9, 2023

Food-drug Interaction Trial in Quebec (SLC-391)

Completed
  • Food-drug Interaction
  • Quebec, Canada
    Syneos Health Clinique Inc. (Quebec)
Jul 28, 2022

Healthy Trial in Tempe (Omeprazole, Gefapixant)

Completed
  • Healthy
  • Tempe, Arizona
    Celerion
Jul 20, 2022

Pharmacokinetics, Pharmacodynamics Trial in Chula Vista (I004, NovoLog)

Recruiting
  • Pharmacokinetics
  • Pharmacodynamics
  • Chula Vista, California
    Amphastar Study Site
Sep 13, 2022

Post-Traumatic Headache Trial in West Haven (Bupivacaine Injection)

Recruiting
  • Post-Traumatic Headache
  • Bupivacaine Injection
  • West Haven, Connecticut
    VA Connecticut Healthcare System
Sep 28, 2023